U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C32H28N6O8
Molecular Weight 624.6001
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BISNAFIDE

SMILES

C[C@H](CNCCNC[C@@H](C)N1C(=O)C2=CC=CC3=CC(=CC(C1=O)=C23)[N+]([O-])=O)N4C(=O)C5=CC=CC6=CC(=CC(C4=O)=C56)[N+]([O-])=O

InChI

InChIKey=PXBZKHOQHTVCSQ-QZTJIDSGSA-N
InChI=1S/C32H28N6O8/c1-17(35-29(39)23-7-3-5-19-11-21(37(43)44)13-25(27(19)23)31(35)41)15-33-9-10-34-16-18(2)36-30(40)24-8-4-6-20-12-22(38(45)46)14-26(28(20)24)32(36)42/h3-8,11-14,17-18,33-34H,9-10,15-16H2,1-2H3/t17-,18-/m1/s1

HIDE SMILES / InChI

Molecular Formula C32H28N6O8
Molecular Weight 624.6001
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Bisnafide (previously known as DMP 840), a bis-naphthalimide derivative that was developed by Bristol-Myers Squibb as a potential anticancer agent. Bisnafide acts as DNA intercalator and topo II inhibitor. This drug participated in phase I clinical trials in pediatric patients with refractory solid tumors. However, further, development has been discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed

Sample Use Guides

10 patients with refractory pediatric solid tumors to this Phase I study of DMP 840 given intravenously by short infusion daily for 5 days
Route of Administration: Intravenous
In Vitro Use Guide
DMP 840 exhibits potent antiproliferative activity in vitro against a variety of human and murine leukemia and solid tumor cell lines in culture, with inhibitory doses that reduce the number of treated cells to one half (IC50) values ranging from 2.3 to 53 nM.
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:57:22 UTC 2023
Edited
by admin
on Sat Dec 16 16:57:22 UTC 2023
Record UNII
62H4W26906
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BISNAFIDE
INN   WHO-DD  
INN  
Official Name English
Bisnafide [WHO-DD]
Common Name English
bisnafide [INN]
Common Name English
1H-BENZ(DE)ISOQUINOLINE-1,3(2H)-DIONE, 2,2'-(1,2-ETHANEDIYLBIS(IMINO((1R)-1-METHYL-2,1-ETHANEDIYL)))BIS(5-NITRO-
Common Name English
N,N'-(ETHYLENEBIS(IMINO((R)-1-METHYLETHYLENE)))BIS(3-NITRONAPHTHALIMIDE)
Common Name English
1H-BENZ(DE)ISOQUINOLINE-1,3(2H)-DIONE, 2,2'-(1,2-ETHANEDIYLBIS(IMINO(1-METHYL-2,1-ETHANEDIYL)))BIS(5-NITRO-, (R-(R*,R*))-
Common Name English
VERSALUMA
Brand Name English
Classification Tree Code System Code
NCI_THESAURUS C582
Created by admin on Sat Dec 16 16:57:22 UTC 2023 , Edited by admin on Sat Dec 16 16:57:22 UTC 2023
Code System Code Type Description
INN
7368
Created by admin on Sat Dec 16 16:57:22 UTC 2023 , Edited by admin on Sat Dec 16 16:57:22 UTC 2023
PRIMARY
PUBCHEM
60917
Created by admin on Sat Dec 16 16:57:22 UTC 2023 , Edited by admin on Sat Dec 16 16:57:22 UTC 2023
PRIMARY
FDA UNII
62H4W26906
Created by admin on Sat Dec 16 16:57:22 UTC 2023 , Edited by admin on Sat Dec 16 16:57:22 UTC 2023
PRIMARY
ChEMBL
CHEMBL1178861
Created by admin on Sat Dec 16 16:57:22 UTC 2023 , Edited by admin on Sat Dec 16 16:57:22 UTC 2023
PRIMARY
MESH
C084899
Created by admin on Sat Dec 16 16:57:22 UTC 2023 , Edited by admin on Sat Dec 16 16:57:22 UTC 2023
PRIMARY
CAS
144849-63-8
Created by admin on Sat Dec 16 16:57:22 UTC 2023 , Edited by admin on Sat Dec 16 16:57:22 UTC 2023
PRIMARY
SMS_ID
100000086320
Created by admin on Sat Dec 16 16:57:22 UTC 2023 , Edited by admin on Sat Dec 16 16:57:22 UTC 2023
PRIMARY
NCI_THESAURUS
C73611
Created by admin on Sat Dec 16 16:57:22 UTC 2023 , Edited by admin on Sat Dec 16 16:57:22 UTC 2023
PRIMARY
EVMPD
SUB05853MIG
Created by admin on Sat Dec 16 16:57:22 UTC 2023 , Edited by admin on Sat Dec 16 16:57:22 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY